| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.43 | 0.3 |